Skip to Main Content
TRC_Tech_Canada
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Do Not Crush List
    • New Drugs
    • Original Container Meds
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. Insulin

Insulin

  • Diabetes (599)
    • Blood Glucose Meters (7)
    • Complications (108)
    • Diabetes in Pregnancy (4)
    • Diabetes Meds (73)
    • Drug-Induced Hypo/Hyperglycemia (99)
    • Monitoring (86)
    • Natural Medicines/Supplements (11)
    • Prevention (26)
    • Treatment (217)
      • Alpha-Glucosidase Inhibitors (21)
      • Amylin Agonist (10)
      • Bromocriptine (4)
      • Combination Products (17)
      • Gliptins (63)
      • Glitazones (72)
      • GLP-1 (31)
      • Incretin Enhancers/Mimetics (46)
      • Insulin (128)
      • Meglitinides (32)
      • Metformin (94)
      • SGLT2 Inhibitors (56)
      • Sulfonylureas (80)
      • Treatment of Pediatric Metabolic Syndrome (3)
  • Endocrinology (10)
  • Hyperglycemia (25)
  • Hypoglycemia (23)
  • Other (21)
  • Prediabetes (2)
  • Resources (132)
  • Thyroid Disorders (51)
121 - 128 of 128 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: Insulin Use in Patients with Type 2 Diabetes November 2008
Guideline: ADA Position Statement on Standards of Medical Care in Diabetes - 2008 November 2008
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) November 2007
Other: Info for Healthcare Providers About the Discontinuation of Exubera November 2007
Commentary: Exubera Off the Market November 2007
Article: Canadians will still be able to get pork insulin November 2006
Other: Hypurin Regular and Hypurin NPH (Pork) Insulins November 2006
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) November 2006
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved